Login

Ben McMillan, CIO of IDX Digital Assets, discusses crypto prices in the context of ongoing macroeconomic volatility. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Kingsgate's Return to Diggers and Dealers: A Decade of Evolution and Upcoming Plans
00:10:00
KSN Mining Unveils $100 Million Workshop Investment in Augusta
00:10:00
Bradesco's Strategic Shift: A Deep Dive into Marcelo Noronha's Insights | Marcelo Noronha, CEO, Banco Bradesco S.A.
00:10:00
Mamba Exploration Strikes Hard with Multiple Project Exploration Campaigns | Mike Dunbar , CEO ,Mamba Exploration.
00:10:00
Embracing the Future: Wisdom Tree's Journey into Digital Assets and Tokenization |   Jonathan Steinberg, CEO ,WisdomTree Investments.
00:10:00
Embracing Data Governance and Technology in Modern Mining Practices
00:10:00
Column Capital: Tailored Financial Solutions for High Net Worth Individuals
00:10:00
Behind the Scenes with Matt Roberts: An Exclusive Interview | Matt Roberts, Chief Planning Officer, Financial Planner of Syverson Strege
00:10:00
Galaxy Digital Founder & CEO Mike Novogratz discusses crypto on CNBC FA.
00:00:00
Facial Paralysis: Is Surgery Necessary - Samir Mardini, M.D. Facial Plastic Surgeon, Mayo clinic
00:10:00
"Exploring ESG and Responsible Investing: A Discussion with State Street Global Advisors' Brie Williams, Hosted by SoFi's Brian Walsh"
00:10:00
Patrick Stokes (Gibson Dunn) Discusses the Importance of the Foreign Extortion Prevention Act for Companies | Barbara L. Becker - Chair & Managing Partner of gibson dunn

© 2017 - Neuhu+